Al-Musawa Fatima Essa, Al-Saqladi Abdul-Wahab M
Department of Pediatrics, Faculty of Medicine and Health Sciences, University of Aden, Aden, Yemen.
Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):832-842. doi: 10.4103/1319-2442.265459.
Microalbuminuria (MA) has been recognized as a sensitive marker of early glomerular injury and a predictor of kidney dysfunction in patients with sickle cell disease (SCD). Limited data are available about MA in SCD children in the Arab countries and none from Yemen. The aim of this study is to determine the prevalence and correlates of MA among 101 children aged 1-16 years, with SCD at their steady state. Children were recruited during their routine health-care visits to the pediatric outpatient clinic in Al-Sadaqa general teaching hospital, Aden, Yemen, between September 2014 and February 2015. A random spot urine sample for each child was screened for MA using Micral-Test strips method. Data on clinical history, anthropometry, blood pressure (BP), and laboratory investigations were obtained. The overall prevalence of MA in this sample was 30.7%, with male predominance (80.6%) (P <0.05). The mean age of children with MA was 7.5 ± 3.2 years, and 10% of them were under five years of age. MA was correlated to both hemoglobin and hematocrit levels, which found to have protective effect against MA (Odds ratio = 0.17 and 0.59, respectively, P <0.05). No correlations were found between MA with age, height, weight, body mass index, recurrent clinical events (painful crises, blood transfusions, and hospitalizations), or fetal hemoglobin levels. BP measurements for all individuals were within the normal ranges, but systolic and diastolic BP were significantly higher in those with MA than without. This study demonstrated a high prevalence of MA in Yemeni children with SCD, and affecting young children as early as 2.5 years of age. Screening for MA as one of the early renal injury markers in children with SCD may help in the prevention of permanent loss of renal function and subsequent renal insufficiency in adulthood.
微量白蛋白尿(MA)已被公认为是早期肾小球损伤的敏感标志物,也是镰状细胞病(SCD)患者肾功能障碍的预测指标。关于阿拉伯国家SCD儿童的MA数据有限,也门则尚无相关数据。本研究旨在确定101名年龄在1至16岁、处于疾病稳定期的SCD儿童中MA的患病率及其相关因素。2014年9月至2015年2月期间,在也门亚丁萨达卡综合教学医院儿科门诊对儿童进行常规保健访视时招募了这些儿童。使用Micral-Test试纸法对每个儿童的随机晨尿样本进行MA筛查。获取了临床病史、人体测量学、血压(BP)和实验室检查的数据。该样本中MA的总体患病率为30.7%,男性占优势(80.6%)(P<0.05)。MA患儿的平均年龄为7.5±3.2岁,其中10%年龄在5岁以下。MA与血红蛋白和血细胞比容水平均相关,这两者对MA具有保护作用(优势比分别为0.17和0.59,P<0.05)。未发现MA与年龄、身高、体重、体重指数、复发性临床事件(疼痛性危象、输血和住院)或胎儿血红蛋白水平之间存在相关性。所有个体的血压测量值均在正常范围内,但有MA者的收缩压和舒张压显著高于无MA者。本研究表明,也门SCD儿童中MA的患病率较高,且早在2.5岁时就会影响幼儿。将MA作为SCD儿童早期肾损伤标志物之一进行筛查,可能有助于预防成年期永久性肾功能丧失和随后的肾功能不全。